The North America Opioids Market would witness market growth of 3.2% CAGR during the forecast period (2021-2027).
Physician anesthesiologists, who specialize in anesthesia, pain management, and critical care medicine, have significant training and experience administering both opioid and non-opioid pain drugs. If a patient requires assistance with pain management, a medical anesthesiologist can work with them to ensure that their pain is controlled while reducing side effects and the danger of addiction.
Opioids function by binding to opioid receptors in the brain and other parts of the body, inhibiting pain signals from the body from reaching the brain. Many individuals find relief after taking the medicine because it masks pain.
Doctors at the Valley Medical Pain Clinic in Minneapolis believe that if opioids are administered in the appropriate dose and according to instructions, they can benefit patients with severe and chronic pain. Patients are at risk of developing an opioid addiction if they use opioids for a long time to address long-term pain. This is why opioids should only be used under the guidance of a doctor.
The demand for opioids is growing substantially in the United Stated, owing to the rising frequency of chronic diseases and the widespread use of opioids as a pain reliever and for illicit purposes. The United States is concentrating its efforts on branded opioid manufacturers looking to launch new medications in order to comply with updated regulatory rules. Furthermore, the United States has dominated the pain management field thanks to government backing for continuous clinical research.
Pfizer, Janssen Pharmaceuticals, Purdue Pharmaceuticals L.P., Assertio Therapeutics, and other North American corporations have all contributed to the country's impressive results. Purdue was the first business to provide opioids with abuse-deterrent formulations qualities, due to the creation of innovative formulations and abuse deterrence research.
The US market dominated the North America Opioids Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,545 million by 2027. The Canada market is experiencing a CAGR of 5.5% during (2021 - 2027). Additionally, The Mexico market would exhibit a CAGR of 4.6% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Opioids Market is Estimated to reach $5.4 Billion by 2027, at a CAGR of 3.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Pain Management
- Cough Treatment and
- Diarrhea Treatment
By Product Type
- Methadone
- Oxycodone
- Hydrocodone
- Fentanyl
- Codeine
- Morphine and
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Opioids Market, by Application
1.4.2 North America Opioids Market, by Product Type
1.4.3 North America Opioids Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Opioids Market by Application
3.1 North America Pain Management Market by Country
3.2 North America Cough Treatment Market by Country
3.3 North America Diarrhea Treatment Market by Country
Chapter 4. North America Opioids Market by Product Type
4.1 North America Methadone Market by Country
4.2 North America Oxycodone Market by Country
4.3 North America Hydrocodone Market by Country
4.4 North America Fentanyl Market by Country
4.5 North America Codeine Market by Country
4.6 North America Morphine Market by Country
4.7 North America Other Product Type Market by Country
Chapter 5. North America Opioids Market by Country
5.1 US Opioids Market
5.1.1 US Opioids Market by Application
5.1.2 US Opioids Market by Product Type
5.2 Canada Opioids Market
5.2.1 Canada Opioids Market by Application
5.2.2 Canada Opioids Market by Product Type
5.3 Mexico Opioids Market
5.3.1 Mexico Opioids Market by Application
5.3.2 Mexico Opioids Market by Product Type
5.4 Rest of North America Opioids Market
5.4.1 Rest of North America Opioids Market by Application
5.4.2 Rest of North America Opioids Market by Product Type
Chapter 6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 AstraZeneca PLC
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.3 Boehringer Ingelheim International Gmbh
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.1 Financial Analysis
6.5.2 Segmental and Regional Analysis
6.5.3 Research & Development Expense
6.6 Sanofi S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Acquisition and Mergers:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.1 Financial Analysis
6.7.2 Regional Analysis
6.7.3 Research & Development Expense
6.7.4 Recent strategies and developments:
6.7.4.1 Approvals and Trials:
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.8.5.2 Approvals and Trials:
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Purdue Pharma L.P.
6.10.1 Company Overview
TABLE 1 North America Opioids Market, 2017 - 2020, USD Million
TABLE 2 North America Opioids Market, 2021 - 2027, USD Million
TABLE 3 North America Opioids Market by Application, 2017 - 2020, USD Million
TABLE 4 North America Opioids Market by Application, 2021 - 2027, USD Million
TABLE 5 North America Pain Management Market by Country, 2017 - 2020, USD Million
TABLE 6 North America Pain Management Market by Country, 2021 - 2027, USD Million
TABLE 7 North America Cough Treatment Market by Country, 2017 - 2020, USD Million
TABLE 8 North America Cough Treatment Market by Country, 2021 - 2027, USD Million
TABLE 9 North America Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
TABLE 10 North America Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
TABLE 11 North America Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 12 North America Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 13 North America Methadone Market by Country, 2017 - 2020, USD Million
TABLE 14 North America Methadone Market by Country, 2021 - 2027, USD Million
TABLE 15 North America Oxycodone Market by Country, 2017 - 2020, USD Million
TABLE 16 North America Oxycodone Market by Country, 2021 - 2027, USD Million
TABLE 17 North America Hydrocodone Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Hydrocodone Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Fentanyl Market by Country, 2017 - 2020, USD Million
TABLE 20 North America Fentanyl Market by Country, 2021 - 2027, USD Million
TABLE 21 North America Codeine Market by Country, 2017 - 2020, USD Million
TABLE 22 North America Codeine Market by Country, 2021 - 2027, USD Million
TABLE 23 North America Morphine Market by Country, 2017 - 2020, USD Million
TABLE 24 North America Morphine Market by Country, 2021 - 2027, USD Million
TABLE 25 North America Other Product Type Market by Country, 2017 - 2020, USD Million
TABLE 26 North America Other Product Type Market by Country, 2021 - 2027, USD Million
TABLE 27 North America Opioids Market by Country, 2017 - 2020, USD Million
TABLE 28 North America Opioids Market by Country, 2021 - 2027, USD Million
TABLE 29 US Opioids Market, 2017 - 2020, USD Million
TABLE 30 US Opioids Market, 2021 - 2027, USD Million
TABLE 31 US Opioids Market by Application, 2017 - 2020, USD Million
TABLE 32 US Opioids Market by Application, 2021 - 2027, USD Million
TABLE 33 US Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 34 US Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 35 Canada Opioids Market, 2017 - 2020, USD Million
TABLE 36 Canada Opioids Market, 2021 - 2027, USD Million
TABLE 37 Canada Opioids Market by Application, 2017 - 2020, USD Million
TABLE 38 Canada Opioids Market by Application, 2021 - 2027, USD Million
TABLE 39 Canada Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 40 Canada Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 41 Mexico Opioids Market, 2017 - 2020, USD Million
TABLE 42 Mexico Opioids Market, 2021 - 2027, USD Million
TABLE 43 Mexico Opioids Market by Application, 2017 - 2020, USD Million
TABLE 44 Mexico Opioids Market by Application, 2021 - 2027, USD Million
TABLE 45 Mexico Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 46 Mexico Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 47 Rest of North America Opioids Market, 2017 - 2020, USD Million
TABLE 48 Rest of North America Opioids Market, 2021 - 2027, USD Million
TABLE 49 Rest of North America Opioids Market by Application, 2017 - 2020, USD Million
TABLE 50 Rest of North America Opioids Market by Application, 2021 - 2027, USD Million
TABLE 51 Rest of North America Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 52 Rest of North America Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 53 Key information –Johnson and Johnson
TABLE 54 Key Information – AstraZeneca PLC
TABLE 55 Key Information – Boehringer Ingelheim International GmbH
TABLE 56 key Information – Endo International PLC
TABLE 57 Key information – Mallinckrodt PLC
TABLE 58 Key Information – Sanofi S.A.
TABLE 59 Key Information – Pfizer, Inc.
TABLE 60 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 61 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 62 Key Information – Purdue Pharma L.P.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.